Achieve Life Sciences (ACHV) Enterprise Value (2010 - 2026)
Achieve Life Sciences (ACHV) posted Enterprise Value of -$30.5 million for Q1 2026, up 41.22% on a QoQ basis from -$51.9 million in Q4 2025, and down 31.17% year-over-year from -$44.3 million in Q1 2025.
Achieve Life Sciences (ACHV) Enterprise Value (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Enterprise Value history runs 17 years deep, the most recent figure standing at -$30.5 million for Q1 2026.
- Quarterly Enterprise Value fell 31.17% year-over-year to -$30.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.5 million (down 31.17% YoY) and the FY2025 annual result came in at -$51.9 million, down 50.97% from the prior year.
- Enterprise Value was -$30.5 million for Q1 2026 at Achieve Life Sciences, up from -$51.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$14.3 million in Q4 2023 and bottomed at -$66.4 million in Q1 2024.
- A 5-year average of -$35.9 million and a median of -$30.5 million in 2026 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value plunged 302.08% — and 2025, when it jumped 64.99%.
- Achieve Life Sciences' Enterprise Value stood at -$24.8 million in 2022, then surged by 42.46% to -$14.3 million in 2023, then slumped by 141.09% to -$34.4 million in 2024, then tumbled by 50.97% to -$51.9 million in 2025, then jumped by 41.22% to -$30.5 million in 2026.
- Business Quant data shows ACHV's Enterprise Value at -$30.5 million in Q1 2026, -$51.9 million in Q4 2025, and -$64.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | -30.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.49 Mn |
| Dec 31, 2025 | -51.88 Mn |
| Sep 30, 2025 | -64.28 Mn |
| Jun 30, 2025 | -54.71 Mn |
| Mar 31, 2025 | -23.25 Mn |
| Dec 31, 2024 | -34.36 Mn |
| Sep 30, 2024 | -42.91 Mn |
| Jun 30, 2024 | -61.02 Mn |
| Mar 31, 2024 | -66.40 Mn |
| Dec 31, 2023 | -14.25 Mn |
| Sep 30, 2023 | -17.92 Mn |
| Jun 30, 2023 | -25.10 Mn |
| Mar 31, 2023 | -16.51 Mn |
| Dec 31, 2022 | -24.77 Mn |
| Sep 30, 2022 | -18.20 Mn |
| Jun 30, 2022 | -27.98 Mn |
| Mar 31, 2022 | -36.34 Mn |
| Dec 31, 2021 | -41.86 Mn |
| Sep 30, 2021 | -23.51 Mn |
| Jun 30, 2021 | -42.00 Mn |